Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,150.00
0.00 (0.00%)
Apr 20, 2026, 5:29 PM IDT

TLV:REKA Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
131125151169176266
Market Cap Growth
-16.91%-17.43%-10.35%-3.96%-33.89%-13.13%
Enterprise Value
259254295338321420
Last Close Price
11.5010.9413.2514.7815.3922.40
PE Ratio
--24.37--40.12
PS Ratio
0.440.420.470.520.601.01
PB Ratio
0.910.870.931.081.081.54
P/TBV Ratio
1.491.421.501.901.391.90
P/FCF Ratio
22.1621.088.4710.015.4834.59
P/OCF Ratio
10.149.645.705.954.5012.55
EV/Sales Ratio
0.860.850.921.051.101.59
EV/EBITDA Ratio
11.1516.5811.7210.317.8711.73
EV/EBIT Ratio
---116.4324.2032.49
EV/FCF Ratio
43.7842.9616.5320.0710.0054.61
Debt / Equity Ratio
0.920.920.831.181.020.96
Debt / EBITDA Ratio
5.675.675.335.604.074.64
Debt / FCF Ratio
22.3522.357.5210.895.1721.59
Net Debt / Equity Ratio
0.890.890.791.060.900.85
Net Debt / EBITDA Ratio
8.348.345.055.013.574.12
Net Debt / FCF Ratio
21.6121.617.129.744.5319.16
Asset Turnover
0.690.690.690.690.660.62
Inventory Turnover
2.672.672.792.562.352.12
Quick Ratio
0.920.920.901.011.061.30
Current Ratio
1.531.531.451.751.752.25
Return on Equity (ROE)
-11.81%-11.81%3.91%-4.35%-1.22%3.91%
Return on Assets (ROA)
-1.04%-1.04%-0.98%0.39%1.87%1.88%
Return on Invested Capital (ROIC)
-2.62%-2.58%-1.89%0.93%-24.16%3.60%
Return on Capital Employed (ROCE)
-2.70%-2.70%-2.50%0.90%4.30%3.80%
Earnings Yield
-13.77%-14.47%4.10%-4.10%-1.16%2.49%
FCF Yield
4.51%4.74%11.80%9.99%18.25%2.89%
Dividend Yield
-----3.87%
Total Shareholder Return
-----3.87%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.